1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 331 F.Supp.3d
  5. 331 F.Supp.3d 1413 (2018)
 

EVONIK REXIM (NANNING) PHARMACEUTICAL LTD. v. US

Slip Op. 18-112 Court No. 17-00132.

331 F.Supp.3d 1413 (2018)

EVONIK REXIM (NANNING) PHARMACEUTICAL CO. LTD. and Evonik Corporation, Plaintiffs, v. UNITED STATES, Defendant.

United States Court of International Trade.

Dated: September 7, 2018.

Attorney(s) appearing for the Case

Matthew T. McGrath, Barnes, Richardson & Colburn, LLP, of Washington, D.C., for Plaintiffs Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. and Evonik Corporation.

Joshua E. Kurland, Trial Attorney, Commercial Litigation Branch, Civil Division, U.S. Department of Justice, of Washington, D.C., for Defendant United States. Of counsel was David W. Campbell, Attorney, Office of Chief Counsel for Trade Enforcement and Compliance, U.S. Department of Commerce, of Washington, D.C.

OPINION

Plaintiffs Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. and Evonik Corporation (collectively, "Evonik") challenge the final decision issued by the U.S. Department of Commerce ("Commerce" or "Department") in the administrative review of...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases